Brainomix, a company offering AI-powered imaging tools for stroke and lung fibrosis, announced the completion of an $18 million Series C investment round.The round was co-led by existing investors Parkwalk Advisors and the Boehringer…
Continue Reading
Background: Lung cancer ranks as the leading cause of cancer-related deaths. For lung cancer survivors, cardiopulmonary fitness is a strong independent predictor of survival, while surgical interventions impact both cardiovascular and pulmonary function. Home-based…
Continue Reading
Coreline Soft announces Australia launch, new FDA approvalSouth Korean medical imaging AI company Coreline Soft has made its way to Australia after securing a partnership with a major medical device supplier.
It entered into a…
Every year, we compile a comprehensive list of the most promising startups poised to transform their industries, and this is our 2025 edition.In this video, we take an in-depth look at 7 groundbreaking digital…
Continue Reading
This study investigates the application of prompt engineering to optimize prompt-driven ChatGPT for generating electronic medical records (EMRs) during lung nodule screening. We assessed the performance of ChatGPT in generating EMRs from patient–provider verbal…
Continue Reading
What You Should Know:
– Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
– The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare,…
Continue Reading
Existing prognostic models are useful for estimating the prognosis of lung adenocarcinoma patients, but there remains room for improvement. In the current study, we developed a deep learning model based on histopathological images to…
Continue Reading
Simon Rasalingham, chief executive of Behold.ai (Credit: Prix Galien International)
UK-based digital health start-up Behold.ai has entered administration after failing to win any contracts under the government’s AI Diagnostic Fund.
Behold.ai supplies lung cancer AI…
In this interview, Dr. Samir Shah, Chief Medical Officer at Qure.ai, shares why achieving FDA approval is crucial for their AI solutions and for fostering trust in the technology. Dr. Shah discusses how their…
Continue Reading
Claire Peacock, clinical exercise physiologist at UHNM (second left), with members of UHNM’s Heart Support Group (Credit: University Hospitals of North Midlands NHS Trust)
The Heart and Lung Centre at University Hospitals of North…
Continue Reading
